Correlation Between AngioDynamics and GlucoTrack
Can any of the company-specific risk be diversified away by investing in both AngioDynamics and GlucoTrack at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AngioDynamics and GlucoTrack into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AngioDynamics and GlucoTrack, you can compare the effects of market volatilities on AngioDynamics and GlucoTrack and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AngioDynamics with a short position of GlucoTrack. Check out your portfolio center. Please also check ongoing floating volatility patterns of AngioDynamics and GlucoTrack.
Diversification Opportunities for AngioDynamics and GlucoTrack
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between AngioDynamics and GlucoTrack is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding AngioDynamics and GlucoTrack in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GlucoTrack and AngioDynamics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AngioDynamics are associated (or correlated) with GlucoTrack. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GlucoTrack has no effect on the direction of AngioDynamics i.e., AngioDynamics and GlucoTrack go up and down completely randomly.
Pair Corralation between AngioDynamics and GlucoTrack
Given the investment horizon of 90 days AngioDynamics is expected to generate 0.14 times more return on investment than GlucoTrack. However, AngioDynamics is 7.37 times less risky than GlucoTrack. It trades about 0.07 of its potential returns per unit of risk. GlucoTrack is currently generating about -0.26 per unit of risk. If you would invest 675.00 in AngioDynamics on August 28, 2024 and sell it today you would earn a total of 24.00 from holding AngioDynamics or generate 3.56% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
AngioDynamics vs. GlucoTrack
Performance |
| Timeline |
| AngioDynamics |
| GlucoTrack |
AngioDynamics and GlucoTrack Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AngioDynamics and GlucoTrack
The main advantage of trading using opposite AngioDynamics and GlucoTrack positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AngioDynamics position performs unexpectedly, GlucoTrack can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GlucoTrack will offset losses from the drop in GlucoTrack's long position.| AngioDynamics vs. AptarGroup | AngioDynamics vs. Repro Med Systems | AngioDynamics vs. AtriCure | AngioDynamics vs. Akoya Biosciences |
| GlucoTrack vs. Heartbeam | GlucoTrack vs. EUDA Health Holdings | GlucoTrack vs. Nutex Health | GlucoTrack vs. Healthcare Triangle |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |